Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3869430 | The Journal of Urology | 2010 | 6 Pages |
Abstract
In this prospective study the incidence of gynecomastia was not as high as previously believed. Although prophylactic breast irradiation seemed to decrease the gynecomastia rate in patients on 150 mg bicalutamide, our study proves that not all patients need prophylaxis since only 52% were significantly bothered by gynecomastia. Thus, individual assessment is needed to select patients who need prophylactic radiation while on 150 mg bicalutamide.
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Haluk Ozen, Fadil Akyol, Gokhan Toktas, Saadettin Eskicorapci, Erdinc Unluer, Ugur Kuyumcuoglu, Erkan Abay, Ibrahim Cureklibatur, Meric Sengoz, Veli Yalcin, Haluk Akpinar, Ferruh Zorlu, Feridun Sengor, Ihsan Karaman,